SEC Form 4 · accession 0001209191-15-076841
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Deina H Walsh
Officer — Chief Financial Officer
Period of report
Nov 4, 2014
Accepted (ET)
Oct 27, 2015 · 9:45 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $1.00 | Nov 4, 2014 | A | 174,918 | A | — | Nov 4, 2024 | Common Stock | 174,918 | 174,918 | D |
Explanation of responses
- F1The options shall vest and become exercisable in three equal installments on each of November 4, 2014, November 4, 2015 and November 4, 2016.